Elevated expression of HMGB1 in squamous-cell carcinoma of the head and neck and its clinical significance

Ma "Differential gene expression profiling of laryngeal squamous cell carcinoma by laser capture microdissection and complementary DNA microarrays" Arch Med Res (2009) 10.1016/j.arcmed.2008.12.005

[4]

Bianchi "Upwardly mobile proteins. Workshop: the role of HMG proteins in chromatin structure, gene expression and neoplasia" EMBO Rep (2000) 10.1093/embo-reports/kvd030

[5]

Kwon "Accessibility of nucleosomal DNA to V(D)J cleavage is modulated by RSS positioning and HMG1" Mol Cell (1998) 10.1016/s1097-2765(00)80297-x

[6]

Müller "New EMBO members’ review: the double life of HMGB1 chromatin protein: architectural factor and extracellular signal" EMBO J (2001) 10.1093/emboj/20.16.4337

[7]

Lotze "High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal" Nat Rev Immunol (2005) 10.1038/nri1594

[8]

Kostova "The expression of HMGB1 protein and its receptor RAGE in human malignant tumors" Mol Cell Biochem (2010) 10.1007/s11010-009-0305-0

[9]

Choi "Overexpression of high mobility group box 1 in gastrointestinal stromal tumors with KIT mutation" Cancer Res (2003)

[10]

Kuniyasu "Co-expression of receptor for advanced glycation end products and the ligand amphoterin associates closely with metastasis of colorectal cancer" Oncol Rep (2003)

[11]

Ishiguro "Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development" Prostate (2005) 10.1002/pros.20219

[12]

Kuniyasu "Amphoterin induction in prostatic stromal cells by androgen deprivation is associated with metastatic prostate cancer" Oncol Rep (2003)

[13]

Increased expression of high mobility group box 1 (HMGB1) is associated with progression and poor prognosis in human nasopharyngeal carcinoma

D Wu, Y DING, S Wang et al.

The Journal of Pathology 2008 10.1002/path.2391

[14]

Brezniceanu "HMGB1 inhibits cell death in yeast and mammalian cells and is abundantly expressed in human breast carcinoma" FASEB J (2003) 10.1096/fj.02-0621fje

[15]

Schlueter "Angiogenetic signaling through hypoxia: HMGB1: an angiogenetic switch molecule" Am J Pathol (2005) 10.1016/s0002-9440(10)62344-9

[16]

Dong Xda "High mobility group box I (HMGB1) release from tumor cells after treatment: implications for development of targeted chemoimmunotherapy" J Immunother (2007) 10.1097/cji.0b013e31804efc76

[17]

Kuniyasu "Expression of receptors for advanced glycation end-products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer" J Pathol (2002) 10.1002/path.1031

[18]

Sobin (2002)

[19]

Zhang "A lymph node metastatic mouse model reveals alterations of metastasis-related gene expression in metastatic human oral carcinoma sublines selected from a poorly metastatic parental cell line" Cancer (2002) 10.1002/cncr.10837

[20]

Cerezo "Prognostic factors for survival and tumor control in cervical lymph node metastases from head and neck cancer. A multivariate study of 492 cases" Cancer (1992) 10.1002/cncr.2820690526

[21]

Tang "High-mobility group box 1 and cancer" Biochim Biophys Acta (2010) 10.1016/j.bbagrm.2009.11.014

[22]

Kepp "Immunogenic cell death modalities and their impact on cancer treatment" Apoptosis (2009) 10.1007/s10495-008-0303-9

[23]

Stros "High-affinity binding of tumor-suppressor protein p53 and HMGB1 to hemicatenated DNA loops" Biochemistry (2004) 10.1021/bi049928k

[24]

Stros "HMGB1 and HMGB2 cell-specifically down-regulate the p53- and p73-dependent sequence-specific transactivation from the human Bax gene promoter" J Biol Chem (2002) 10.1074/jbc.m110233200

[25]

Agresti "HMGB1 interacts differentially with members of the Rel family of transcription factors" Biochem Biophys Res Commun (2003) 10.1016/s0006-291x(03)00184-0

[26]

HMG-1 Stimulates Estrogen Response Element Binding by Estrogen Receptor from Stably Transfected HeLa Cells

Chaocheng Zhang, Sacha Krieg, David J. Shapiro

Molecular Endocrinology 1999 10.1210/mend.13.4.0264

[27]

Ghavami "S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway" J Leukoc Biol (2008) 10.1189/jlb.0607397

[28]

Palumbo "Cells migrating to sites of tissue damage in response to the danger signal HMGB1 require NF-kappaB activation" J Cell Biol (2007) 10.1083/jcb.200704015

[29]

Taguchi "Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases" Nature (2000) 10.1038/35012626

[30]

de Visser "The inflammatory tumor microenvironment and its impact on cancer development" Contrib Microbiol (2006) 10.1159/000092969

[31]

Johann "Clinical proteomics and biomarker discovery" Ann N Y Acad Sci (2004) 10.1196/annals.1318.045

[32]

Maeda "Essential roles of high-mobility group box 1 in the development of murine colitis and colitis-associated cancer" Biochem Biophys Res Commun (2007) 10.1016/j.bbrc.2007.06.065

[33]

Hanford "Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE)" J Biol Chem (2004) 10.1074/jbc.m409782200

Cited By

63

Expression and clinical significance of HMGB1 in human liver cancer: Knockdown inhibits tumor growth and metastasis in vitro and in vivo

YA-DONG DONG, Long Cui · 2012

Oncology Reports

Metrics

63

Citations

33

References

Details

Published: Nov 01, 2010
Vol/Issue: 46(16)
Pages: 3007-3015
License: View

Authors

Y

Yong Liu

1BGI HK Research Institute, 16 Dai Fu Street, Tai Po Industrial Estate, Hong Kong

IBM Research - Thomas J. Watson Research Center

Funding

National Natural Science Foundation of China Award: 30872852

Research Fund for the Doctoral Program of Higher Education of China Award: 20090162110065

Key Program of Natural Science Foundation of Hunan Province Award: 2007SK2003

Cite This Article

Yong Liu, Congliang Xie, Xin Zhang, et al. (2010). Elevated expression of HMGB1 in squamous-cell carcinoma of the head and neck and its clinical significance. European Journal of Cancer, 46(16), 3007-3015. https://doi.org/10.1016/j.ejca.2010.07.016

Elevated expression of HMGB1 in squamous-cell carcinoma of the head and neck and its clinical significance

You May Also Like